What does PHARMACITY do?

PHARMACITY is an insurer in Sint-Pieters-Woluwe. Private Limited, started on 25 July 2000, 1 establishment.

What is the address of PHARMACITY?

The registered office of PHARMACITY is located at Paul Wemaerestraat 4, 1150 Sint-Pieters-Woluwe.

Is PHARMACITY still active?

Yes. According to the CBE (29 October 2026) PHARMACITY is active, legal situation “Normale toestand”, started on 25 July 2000.

Is PHARMACITY registered on Peppol?

Yes, PHARMACITY is registered on the Peppol network with ID 0208:0472480862.

What is the enterprise number of PHARMACITY?

The enterprise number of PHARMACITY is BE0472480862.

When was PHARMACITY founded?

PHARMACITY was founded on 25 July 2000.

Who are the directors of PHARMACITY?

According to the 2025 annual accounts, the directors of PHARMACITY are: Pierre MASSAR, Laurent LACROIX, JEAN ANTOINE LACROIX.

Is PHARMACITY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 July 2000; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did PHARMACITY make in 2025?

PHARMACITY recorded a loss after taxes of € 47,304 in financial year 2025.

What is the revenue of PHARMACITY?

As a small company, PHARMACITY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 97,670.

PHARMACITY (Private Limited) - Sint-Pieters-Woluwe

Dossier PHARMACITY, printed on 29 October 2026 from databakkes.be/en/0472480862/pharmacity. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 5 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACITY from Sint-Pieters-Woluwe, company number BE0472480862, closed financial year 2025 with a result of € -47,304 after tax. For that financial year PHARMACITY recorded a gross margin of € 97,670 and equity of € -296,494. Compared with financial year 2024, the result moved from € -61,327 to € -47,304. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 15, 2026.

What it is worth Caution

€ -296,494

▼ € 47,304 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -47,304

▲ 23 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 74,986

▲ 98% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -789,086.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.1 million

▲ 20% vs 2024

€ 86,741 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 9,812

▲ 138% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 244

▼ 74% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 97,575 Gross margin 2022: € 97,575 First fiscal year in the series	€ 115,021 Gross margin 2023: € 115,021 ▲ 18% vs 2022 (€ 97,575) Favourable step	€ 87,187 Gross margin 2024: € 87,187 ▼ 24% vs 2023 (€ 115,021) Unfavourable step	€ 97,670 Gross margin 2025: € 97,670 ▲ 12% vs 2024 (€ 87,187) Favourable step	▲ 12%
Profit after taxes	€ -87,141 Profit after taxes 2022: € -87,141 First fiscal year in the series	€ -76,259 Profit after taxes 2023: € -76,259 ▲ € 10,882 vs 2022 (€ -87,141) Favourable step	€ -61,327 Profit after taxes 2024: € -61,327 ▲ € 14,932 vs 2023 (€ -76,259) Favourable step	€ -47,304 Profit after taxes 2025: € -47,304 ▲ € 14,023 vs 2024 (€ -61,327) Favourable step	▲ € 14,023
Equity	€ -111,604 Equity 2022: € -111,604 First fiscal year in the series	€ -187,863 Equity 2023: € -187,863 ▼ € 76,259 vs 2022 (€ -111,604) Unfavourable step	€ -249,190 Equity 2024: € -249,190 ▼ € 61,327 vs 2023 (€ -187,863) Unfavourable step	€ -296,494 Equity 2025: € -296,494 ▼ € 47,304 vs 2024 (€ -249,190) Unfavourable step	▼ € 47,304
Total debts	€ 2,369,726 Total debts 2022: € 2,369,726 First fiscal year in the series	€ 2,351,412 Total debts 2023: € 2,351,412 ▼ 1% vs 2022 (€ 2,369,726) Favourable step	€ 2,472,479 Total debts 2024: € 2,472,479 ▲ 5% vs 2023 (€ 2,351,412) Unfavourable step	€ 2,718,317 Total debts 2025: € 2,718,317 ▲ 10% vs 2024 (€ 2,472,479) Unfavourable step	▲ 10%
Cash	€ 47,267 Cash 2022: € 47,267 First fiscal year in the series	€ 47,584 Cash 2023: € 47,584 ▲ 1% vs 2022 (€ 47,267) Favourable step	€ 37,856 Cash 2024: € 37,856 ▼ 20% vs 2023 (€ 47,584) Unfavourable step	€ 74,986 Cash 2025: € 74,986 ▲ 98% vs 2024 (€ 37,856) Favourable step	▲ 98%
Land & buildings	€ 2,031,035 Land & buildings 2022: € 2,031,035 First fiscal year in the series	€ 1,933,232 Land & buildings 2023: € 1,933,232 ▼ 5% vs 2022 (€ 2,031,035) Unchanged	€ 2,086,802 Land & buildings 2024: € 2,086,802 ▲ 8% vs 2023 (€ 1,933,232) Unchanged	€ 2,264,847 Land & buildings 2025: € 2,264,847 ▲ 9% vs 2024 (€ 2,086,802) Unchanged	▲ 9%
Retained profit	€ -604,196 Retained profit 2022: € -604,196 First fiscal year in the series	€ -680,455 Retained profit 2023: € -680,455 ▼ € 76,259 vs 2022 (€ -604,196) Unfavourable step	€ -741,782 Retained profit 2024: € -741,782 ▼ € 61,327 vs 2023 (€ -680,455) Unfavourable step	€ -789,086 Retained profit 2025: € -789,086 ▼ € 47,304 vs 2024 (€ -741,782) Unfavourable step	▼ € 47,304
Bank debt	€ 818,496 Bank debt 2022: € 818,496 First fiscal year in the series	€ 737,470 Bank debt 2023: € 737,470 ▼ 10% vs 2022 (€ 818,496) Favourable step	€ 887,321 Bank debt 2024: € 887,321 ▲ 20% vs 2023 (€ 737,470) Unfavourable step	€ 1,067,688 Bank debt 2025: € 1,067,688 ▲ 20% vs 2024 (€ 887,321) Unfavourable step	▲ 20%
Balance sheet total	€ 2,258,122 Balance sheet total 2022: € 2,258,122 First fiscal year in the series	€ 2,163,549 Balance sheet total 2023: € 2,163,549 ▼ 4% vs 2022 (€ 2,258,122) Unchanged	€ 2,223,289 Balance sheet total 2024: € 2,223,289 ▲ 3% vs 2023 (€ 2,163,549) Unchanged	€ 2,421,823 Balance sheet total 2025: € 2,421,823 ▲ 9% vs 2024 (€ 2,223,289) Unchanged	▲ 9%

Key figures of PHARMACITY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACITY?

What happened at PHARMACITY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 15, 2026 New annual accounts for financial year 2025: loss of € 47,304. filed late Source: NBB ↗
2017 JEAN ANTOINE LACROIX became a director. NBB
2010 Pierre MASSAR became a director. NBB
2010 Laurent LACROIX became a director. NBB
Jul 4, 2001 New establishment in Sint-Pieters-Woluwe. KBO
Jul 25, 2000 Start of the company according to the CBE. KBO

In short

From € 87,141 loss in 2022 to € 47,304 loss in 2025.

Paid € 652 in corporate taxes since 2022.

Original PDFs at the National Bank ↗

Management

Pierre MASSAR Laurent LACROIX JEAN ANTOINE LACROIX

Realteam

PHARMACITY

ASSURTEAM

ALICE

Behind PHARMACITY are Pierre MASSAR, Laurent LACROIX and JEAN ANTOINE LACROIX. Pierre MASSAR is also behind Realteam. Laurent LACROIX is also behind ASSURTEAM, Realteam, LE PARC 1348 and LLX Finance. JEAN ANTOINE LACROIX is also behind ALICE.

Directors

According to the 2025 annual accounts

Pierre MASSAR

Manager

Also active at: Realteam

since 2010

Laurent LACROIX

Manager

Also active at: ASSURTEAM, Realteam, LE PARC 1348, LLX Finance

since 2010

JEAN ANTOINE LACROIX

Manager

Also active at: ALICE

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Paul Wemaerestraat 4

1150 Sint-Pieters-Woluwe

2.094.426.968

Paul Wemaerestraat 2 4 box 6

1150 Sint-Pieters-Woluwe

Active since 4 July 2001

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

ASSURTEAM same network

€ 2.2 million gross margin · 2025

Realteam same network

€ 220,477 gross margin · 2025

UTVA TEAM ASSURFINANCE II

PEJATEN

€ 130,658 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0472.480.862

VAT number

BE 0472.480.862

Registered office

Paul Wemaerestraat 4, 1150 Sint-Pieters-Woluwe

Names & denominations

PHARMACITY

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

25 July 2000

Peppol

Active · Active since 19 Jan 2026

Activities · NACE

Activiteiten van gemengde verzekeringsondernemingen, overwegend leven

Herverzekering

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

Activiteiten van gemengde verzekeringsondernemingen, overwegend niet-leven

Activiteiten van pensioenfondsen

Overige financiële dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACITY

Warning lights

Financials

What happened to PHARMACITY?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions